Ep. 245 - Modern-day FDA, What’s New is Still Old

Ep. 245 - Modern-day FDA, What’s New is Still Old

Picture this: a former chair of the FDA's advisory committee sitting down to discuss the policies and decisions that fueled America's opioid crisis. In this eye-opening episode of Cover 2 Resources, host Greg McNeil dives into a candid conversation with Dr. Raeford Brown, who led the FDA's anesthetic and analgesic drug products advisory committee for five years. Dr. Brown doesn't shy away from tough topics, revealing the FDA's decision-making process, the sway of pharmaceutical companies, and the contentious REMS program.

The episode also revisits the Zohydro saga, shedding light on the agency's controversial approval decisions. Dr. Brown offers a rare insider perspective, questioning whether the FDA has truly learned from past mistakes or remains stuck in old ways. This episode is a must-listen for anyone wanting to understand the complexities behind regulatory decisions that have had far-reaching consequences. Tune in for a thought-provoking discussion that challenges the status quo and explores potential paths forward in addressing the opioid epidemic.